Showing results (571-580 of 601) with videos related to

Sort By:
Pageof 61
Nature Materials|January 19, 2026
Cell viscosity influences haematogenous dissemination and metastatic extravasation of tumour cellsValentin Gensbittel, Zeynep Yesilata, Louis Bochler, et al.
The International Journal of Neuropsychopharmacology|January 10, 2016
Catechol-O-Methyltransferase Val158Met Polymorphism and Clinical Response to Antipsychotic Treatment in Schizophrenia and Schizo-Affective Disorder Patients: a Meta-AnalysisEric Huang, Clement C Zai, Amanda Lisoway, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|October 5, 2023
Influence of CYP2C19, CYP2D6, and ABCB1 Gene Variants and Serum Levels of Escitalopram and Aripiprazole on Treatment-Emergent Sexual Dysfunction: A Canadian Biomarker Integration Network in Depression 1 (CAN-BIND 1) StudyFarhana Islam, Leen Magarbeh, Samar S M Elsheikh, et al.
JAMA Psychiatry|February 11, 2026
One-Year Actigraphy Study of Sleep and Rest-Activity Rhythms as Markers of Relapse in DepressionAndre C Tonon, Adile Nexha, Jasmyn E A Cunningham, et al.
Translational Psychiatry|February 16, 2021
Genome-wide analysis suggests the importance of vascular processes and neuroinflammation in late-life antidepressant responseVictoria S Marshe, Malgorzata Maciukiewicz, Anne-Christin Hauschild, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|June 3, 2019
New insights into tardive dyskinesia genetics: Implementation of whole-exome sequencing approachAnna Alkelai, Lior Greenbaum, Erin L Heinzen, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|March 29, 2025
Polygenic Risk Score Analysis of Antidepressant Treatment Outcomes: A CAN-BIND-1 Study Report: Analyse des résultats du traitement antidépresseur à l'aide des scores de risque polygéniques : Rapport sur l'étude CAN-BIND-1Leen Magarbeh, Samar S M Elsheikh, Farhana Islam, et al.
Psychoneuroendocrinology|July 6, 2021
Hypothalamus volume and DNA methylation of stress axis genes in major depressive disorder: A CAN-BIND study reportJee Su Suh, Laura M Fiori, Mohammad Ali, et al.
Pharmacogenomics|January 7, 2015
Investigation of TSPO variants in schizophrenia and antipsychotic treatment outcomesJennie G Pouget, Vanessa F Gonçalves, Erika L Nurmi, et al.
Pharmacopsychiatry|June 25, 2024
Integrative Genetic Variation, DNA Methylation, and Gene Expression Analysis of Escitalopram and Aripiprazole Treatment Outcomes in Depression: A CAN-BIND-1 StudyFarhana Islam, Amanda Lisoway, Edward S Oh, et al.
Pageof 61